naratriptan
Active substance: naratriptan
TABLET · NARATRIPTAN HYDROCHLORIDE 2.5 mg/1
United StatesActive
Marketing holder: ASCLEMED USA INC.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- NARATRIPTAN HYDROCHLORIDE · 2.5 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-4cd5-7655-b84b-79874acc6e80,01a1208c-a90b-7b5e-b9d0-9348954567b1,01a1208d-9b89-7ac1-bf17-fe74fab03ce7,01a1208d-eff5-7c7a-a72c-8df67754b94f,01a1208e-c17f-7745-b906-bfd1fa602a00;count=8 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 87063-288
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 87063-288 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 87063-288 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 87063-288 · Verified 2026-10-09 · open in source